Park J-S, Oh I H, Lee C H, Kim G-H, Kang C M
Department of Internal Medicine, Hanyang University College of Medicine, Seoul, South Korea.
Transplant Proc. 2013 May;45(4):1438-41. doi: 10.1016/j.transproceed.2012.10.052.
To improve the long-term outcome of kidney transplantation (KT), it is important to identify and take active steps to reduce the number or severity of novel risk factors. We investigated whether changes in estimated glomerular filtration rate over the first year after KT (ΔeGFR12-3) was associated with long-term renal allograft function and survival.
Four hundred twenty-eight allograft recipients transplanted between 1990 and 2001 underwent ΔeGFR12-3 calculation using the equation: ΔeGFR12-3 = ([eGFR at 12 months post-KT - eGFR at 3 months post-KT]/[eGFR at 3 months post-KT]) × 100%. Recipients were divided into 3 groups according to their ΔeGFR12-3: group I (n = 150), ΔeGFR12-3 ≥ 10%; group II (n = 151), 10 > ΔeGFR12-3 ≥ -10%; and group III (n = 127), ΔeGFR12-3 < -10%. Multiple linear regression analysis was used to adjust for confounding variables that may affect long-term renal allograft function, and Kaplan-Meier analysis, to compare allograft survival.
At a mean follow-up of 120 ± 58 months, we observed 112 renal allograft losses. The ΔeGFR over 10 years post-KT (ΔeGFR120-3) was significantly associated with the serum uric acid levels at 3 months post-transplantation and ΔeGFR12-3. Group III showed poor renal allograft survival; group I, 194 ± 8 months; group II, 197 ± 7 month and; group III, 163 ± 4 months; (log-rank test, P < .05). A Cox proportional hazard model revealed ΔeGFR12-3 to be independently associated with future renal allograft loss (hazard ratio, 0.981; 95% confidence interval, 0.974-0.992).
Our results suggested that ΔeGFR12-3 may be an independent predictor of kidney allograft survival. Routine application of eGFR is strongly recommended to identify patients at risk for chronic allograft dysfunction.
为改善肾移植(KT)的长期疗效,识别并积极采取措施减少新风险因素的数量或严重程度非常重要。我们研究了KT后第一年估计肾小球滤过率的变化(ΔeGFR12 - 3)是否与长期肾移植功能及存活相关。
对1990年至2001年间接受移植的428例移植受者,使用公式ΔeGFR12 - 3 =([KT后12个月的eGFR - KT后3个月的eGFR]/[KT后3个月的eGFR])×100%计算ΔeGFR12 - 3。根据ΔeGFR12 - 3将受者分为3组:I组(n = 150),ΔeGFR12 - 3≥10%;II组(n = 151),10>ΔeGFR12 - 3≥ - 10%;III组(n = 127),ΔeGFR12 - 3< - 10%。采用多元线性回归分析调整可能影响长期肾移植功能的混杂变量,并采用Kaplan - Meier分析比较移植肾存活情况。
平均随访120±58个月时,我们观察到112例移植肾失功。KT后10年的ΔeGFR(ΔeGFR120 - 3)与移植后3个月的血清尿酸水平及ΔeGFR12 - 3显著相关。III组移植肾存活情况较差;I组为194±8个月;II组为197±7个月;III组为163±4个月;(对数秩检验,P<0.05)。Cox比例风险模型显示ΔeGFR12 - 3与未来移植肾失功独立相关(风险比,0.981;95%置信区间,0.974 - 0.992)。
我们的结果提示ΔeGFR12 - 3可能是移植肾存活的独立预测指标。强烈建议常规应用eGFR以识别有慢性移植肾功能障碍风险的患者。